Overview

Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Liposom Forte will enhance the response to antidepressant therapy with citalopram in elderly patients suffering from Major Depressive Disorder (MDD).
Phase:
Phase 4
Details
Lead Sponsor:
Fidia Farmaceutici s.p.a.
Treatments:
Citalopram